For patients undergoing tumor-directed RT, it appears that the negative consequences of TGF-β may be at least partly due to RT-induced reduction of the TGF-β pseudoreceptor, bone morphogenetic protein and activin membrane-bound inhibitor (BAMBI) (Figure 1). Here, TGFB1 is linked to neoplasm.